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Background: Hunter syndrome (HS) is a lysosomal storage disease caused by iduronate-2-sulfatase (IDS) deficiency
and loss of ability to break down and recycle the glycosaminoglycans, heparan and dermatan sulfate, leading to
impairment of cellular processes and cell death. Cell activities and functioning of intracellular organelles are
controlled by the clock genes (CGs), driving the rhythmic expression of clock controlled genes (CCGs). We aimed to
evaluate the expression of CGs and downstream CCGs in HS, before and after enzyme replacement treatment with
IDS.
Methods: The expression levels of CGs and CCGs were evaluated by a whole transcriptome analysis through Next
Generation Sequencing in normal primary human fibroblasts and fibroblasts of patients affected by HS before and
24 h/144 h after IDS treatment. The time related expression of CGs after synchronization by serum shock was also
evaluated by qRT-PCR before and after 24 hours of IDS treatment.
Results: In HS fibroblasts we found altered expression of several CGs and CCGs, with dynamic changes 24 h and
144 h after IDS treatment. A semantic hypergraph-based analysis highlighted five gene clusters significantly
associated to important biological processes or pathways, and five genes, AHR, HIF1A, CRY1, ITGA5 and EIF2B3,
proven to be central players in these pathways. After synchronization by serum shock and 24 h treatment with IDS
the expression of ARNTL2 at 10 h (p = 0.036), PER1 at 4 h (p = 0.019), PER2 at 10 h (p = 0.041) and 16 h (p = 0.043)
changed in HS fibroblasts.
Conclusion: CG and CCG expression is altered in HS fibroblasts and IDS treatment determines dynamic
modifications, suggesting a direct involvement of the CG machinery in the physiopathology of cellular
derangements that characterize HS.
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Hunter syndrome (HS), or Mucopolysaccharidosis type II,
is a lysosomal storage disease and a X-linked recessive
genetic disorder caused by a mutation in the IDS gene,
leading to absence or deficiency of the enzyme iduronate-
2-sulfatase (IDS). IDS deficit interferes with the ability to* Correspondence: g.mazzoccoli@operapadrepio.it
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distribution, and reproduction in any mediumbreak down and recycle glycosaminoglycans (GAGs), pre-
cisely dermatan sulfate and heparan sulfate, causes lyso-
somal engulfment, and hinders the customary working of
cellular functions, compromising anatomical integrity in a
number of organ systems and leading to curtailment of life
expectancy [1]. The patients are characterized by coarsen-
ing of facial features, bone and joint abnormalities, short
stature, changes in the heart, respiratory system, hearing
and vision, and in more severe forms by disturbed motor
function, progressive learning difficulties and behav-
ioural abnormalities [2]. Enzyme replacement therapytral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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resents the only affordable therapeutic approach presently.
The cellular processes in every life form from bacteria
to humans show diurnal variations driven by an internal
timing system, and the oscillation frequency has a near-
24-hour period, so that the rhythmicity is defined circa-
dian (from the latin circa, about, and dies, a day) [3-5].
The mammalian circadian timing system is composed by
a central pacemaker and master oscillator in the supra-
chiasmatic nuclei (SCN) of the brain and self-sustained
oscillators in the peripheral tissues [6,7]. The SCN are
entrained to the environmental light/dark cycle by cues
perceived through photon capture, signalling by
melanopsin-containing retinal ganglion cells, and inputs
conveyed by the retino-hypothalamic tract [8]. They
synchronize peripheral oscillators and coordinate bodily
functions by means of output pathways that may be
neural projections (sympathetic and parasympathetic
nerve fibers) or diffusible factors (for example hormones
as cortisol and melatonin) [9,10].
The molecular mechanisms underlying the biological
clock functioning consist of a transcriptional-translational
feedback loop operated by a set of genes, called core clock
genes, coding for proteins that in turn block gene expres-
sion, completing a cycle in approximately 24 hours [11].
The positive limb of the loop is represented by the
CLOCK (or its paralog NPAS2) and ARNTL/BMAL1 (or
its paralog ARNTL2/BMAL2) genes that code for the
transcription factors CLOCK/NPAS2 and ARNTL/2. A
heterodimer of the CLOCK/NPAS2 and ARNTL/2 pro-
teins rhythmically activates the transcription of clock
genes PER1, PER2, PER3, CRY1, CRY2, coding for PER
and CRY proteins that represent the negative limb of
the loop. PER and CRY proteins along with Casein
Kinase Iδ/ε (CKIδ/ε) and Casein Kinase II (CKII A1,
A2, B), responsible of multilevel posttranslational regu-
lation of various clock components, cooperate to form a
repression complex that translocates back into the
nucleus, interacts directly with CLOCK/NPAS2 and
ARNTL/2, and impede their transcriptional activity
[12]. The clock gene machinery is connected to a
supporting feedback loop operated by the nuclear re-
ceptors REV-ERBα/β (encoded by the genes NR1D1 and
NR1D2) and retinoic acid-related orphan receptor (ROR)
α/γ, where RORs positively regulate ARNTL/2 and REV-
ERB expression and, in turn, REV-ERBs antagonize RORs
[13,14]. Besides, SIRT1, a NAD + −dependent protein
and histone deacetylase, is required for high-magnitude
circadian transcription of several core clock genes, in-
cluding ARNTL, PER2, and CRY1. SIRT1 counterbal-
ances the histone acetyltransferase activity of CLOCK,
binds CLOCK-ARNTL heterodimer in a circadian man-
ner and promotes the deacetylation and degradation of
PER2 [15].TIMELESS is a core circadian clock gene in Drosophila
melanogaster and is maintained in mammals, but its role
in mammalian circadian clock function is not clear.
TIMELESS and its partner TIMELESS interacting pro-
tein (TIPIN) interact with components of the DNA rep-
lication system to regulate DNA replication processes
under both normal and stress conditions and are essential
for ataxia telangiectasia and Rad3-related (ATR)-check-
point kinase (Chk)1 and ataxia telangiectasia mutated
(ATM)-checkpoint kinase (Chk)2-mediated signaling and
S-phase arrest [16-19].
The clock gene oscillation drives the rhythmic expression
of other genes defined clock controlled genes, for example
DBP, TEF, HLF, HSF1, NFIL3 (also called E4BP4), DEC1-2
(also called BHLHE40-41), which steer downstream tissue
specific genes regulating key cellular functions, such as cell
cycle progression, proliferation, DNA damage response, au-
tophagy, apoptosis, metabolism, redox equilibrium [20-23],
and are involved in physiological processes such as inflam-
mation/immune response [24,25], and paraphysiological
phenomena, such as aging [26]. About 5% to 15% of
genome-wide mRNA expression exhibits a circadian
rhythm that is driven by the clock genes and there is a tis-
sue specificity of cycling genes and a tissue specificity of
clock controlled gene expression timing and level (output
genes i.e., genes involved in the functional output of an
organ) [27-30]. Accordingly, multicellular organisms are
characterized by tissue-specific circadian regulation of tran-
scription, with peripheral oscillators controlling the definite
biochemical cascades relevant to their tissue or organ func-
tion and generating rhythms in various pathways, including
those involved in intracellular activities and depending on
the correct functioning of intracellular organelles [27-30].
The importance of the role played by the clock gene ma-
chinery in the regulation of the processes in the intracellu-
lar organelles is confirmed by the physiopathology of
Niemann-Pick types A and B disease, related to deficit of
sphingomyelin synthase 2 (SGMS2), the enzyme that cata-
lyzes the transfer of phosphocholine from phosphatidylcho-
line onto ceramide to produce sphingomyelin, a major
component of cell and Golgi membranes. Furthermore,
Niemann-Pick type C disease is related to deficit of
Niemann-Pick C1 (NPC1), which is crucial for the intracel-
lular trafficking of cholesterol from the late endosome to
the trans-Golgi network [31]. SGMS2 and NPC1protein
levels oscillate with circadian rhythmicity driven by the
clock controlled genes SGMS2 and NPC1 respectively
[27,28]. Patients carrying a mutation in these genes develop
a condition characterized by accumulation of sphingomye-
lin in spleen, liver, lungs, bone marrow and brain, causing
irreversible neurological damage, and high cholesterol levels
in the endosomal-lysosomal system, respectively [32].
The aim of our study was to assess the expression of clock
genes and clock controlled genes in Mucopolysaccharidosis
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and the effects of the treatment with idursulfase on the ex-
pression of clock genes and clock controlled genes at
different time points.
We addressed these issues taking advantage of an in vitro
model of HS, represented by human fibroblasts with the
mutational features of this mucopolysaccharidosis, through
evaluation of the mRNA expression levels of the core clock
genes and of a panel of clock controlled genes selected by
means of literature-mining [27-30,33] (for a complete list of
circadian transcripts refer to: CircaDB at http://circadb.
org). These evaluations are part of a whole transcriptome
analysis performed by Next Generation Sequencing (NGS)
in fibroblasts from healthy subjects and fibroblasts from HS
patients before, 24 hours and 144 hours after idursulfase
treatment. We also evaluated by qRT-PCR the expression
levels of core clock genes upon serum-shock induced
synchronization in normal human fibroblasts and fibro-
blasts of patients affected by HS before and after 24 hours
of treatment with idursulfase.
Materials and methods
Cells
Human fibroblasts from skin biopsy of five HS paediatric
patients carrying different mutation in IDS gene were
obtained from “Cell Line and DNA Bank from Patients
Affected by Genetic Diseases”, Gaslini Institute (Genoa,
Italy). As healthy controls human fibroblasts from four
children’s circumcision were used; they were obtained
from the Histology Unit of the Department of Histology,
Microbiology and Medical Biotechnology (University of
Padua, Padua, Italy). Written informed consents were
obtained from patients at the time of biopsy and the
study was approved by the Ethics Committee of the Uni-
versity of Padua, Padua, Italy. All cells were anonym-
ously obtained.
Cell culture and treatment with idursulfase of HS
fibroblasts
Primary fibroblasts were cultured at 37° C in 5% CO2 at-
mosphere in RPMI medium supplemented with 15%
fetal bovine serum (FBS), 100 U/ml penicillin and
100 ng/ml streptomycin (Invitrogen Life Technologies,
Milan, Italy). Fibroblasts of patients affected by HS were
treated with idursulfase (ElapraseW, Shire Human Gen-
etic Therapies, Inc, Lexington, MA, USA) at a concen-
tration of 62.5 nM for 24 hours and the cells were
harvested 24 h and 144 h after idursulfase treatment.
Whole transcriptome analysis performed by NGS
technology
Total RNA was extracted using the TRIzolW Reagent
(Sigma-AldrichW) according to the manufacturer’s proto-
cols. Isolated RNA was quantified by NanoDrop ND-1000 Spectrophotometer (Thermo Scientific, Barnstead,
NH, USA) and further assessed for quality using the
Agilent 2100 Bioanalyzer (Santa Clara, CA) prior to li-
brary construction. Total RNAs extracted from different
cell lines were equally pooled into two specimens
(Hunter and healthy) using 12.5 μg of RNA from each
cell line. From total RNA of each pool mRNA purifica-
tion was performed trough poliA(+) enrichment by
DynabeadsW mRNA Purification Kit (Life Technologies™
Carlsbad, CA, USA). Total RNA was used for standard
fragment-library preparation using the SOLiD Total
RNA-Seq Kit (Life Technologies). Finally, emulsion PCR
reactions were carried out by mixing appropriated
amount of libraries with SOLiD beads. After PCR ampli-
fication, emulsions were broken using butanol, and the
beads were washed, enriched, and terminal transferased
before quantification and deposition onto a slide for se-
quencing. Templated beads were deposited onto one full
slide, one sample for quarter (quad). Sequencing was
carried out to 35 bases using SOLiD™ 3 (Sequencing by
Oligo Ligation and Detection) System and following the
manufacturer’s instructions.
Alignment
Reads obtained from sequencing were aligned on human
genome by CRIBI Biotechnology Centre (University of
Padova) using the PASS software (http://pass.cribi.unipd.it).
The February 2009 human genome assembly (GRCh37),
publicly available at UCSC Genome Bioinformatics Site
(http://genome.ucsc.edu/) was taken as reference sequence
and the options best-hit, gap = 0 and maximun mismach = 3
have been selected. Only unique reads (aligning on only
one gene) and only genes with coverage higher than 50%
of gene length were considered.
Serum-shock induced synchronization and treatment with
idursulfase of HS fibroblasts
The serum shock induced synchronization was per-
formed as follows: approximately 4×105 cells/6 wells
were plated the day before the experiments. Fibroblasts
of patients affected by HS were treated with idursulfase
at a concentration of 62.5 nM for 24 hours (Elaprase,
Shire Human Genetic Therapies, Inc, Lexington, MA,
USA). The day of the experiments, culture medium was
exchanged with serum-rich medium (RPMI containing
50% FBS) and after 2 hours this medium was replaced
with serum free RPMI [34]. The cells were harvested
1 h, 4 h, 10 h, 16 h, 22 h and 28 h after serum shock.
Quantitative real time polymerase chain reaction
(qRT-PCR)
Total RNA was extracted from normal primary human fi-
broblasts and fibroblasts of patients affected by HS before
and after 24 hours of idursulfase treatment at the indicated
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Milan, Italy) and subsequently digested by DNase I. Quanti-
tative Real Time PCR was performed starting from 100 ng
of purified RNA using the one step quantifast SYBR Green
RT PCR KIT (Qiagen). For real-time PCR, we used the fol-
lowing SYBR Green QuantiTect Primers purchased from
Qiagen: ARNTL (QT00068250), ARNTL2 (QT00011844),
CLOCK (QT00054481), CRY1 (QT00025067) PER1
(QT00069265), PER2 (QT00011207), PER3 (QT00097713).
Expression levels of target gene were normalized using the
housekeeping control gene TATA binding protein (TBP,
QT00000721). Values of mRNA expression levels of clock
genes were calculated using the formula 2−ΔΔCt.
Statistical analysis
Results are expressed as means ± SE of at least three differ-
ent experiments. Comparisons were made using Student’s
t-test as appropriate. The limit of statistical significance was
set at to p < 0.001 for comparisons of levels of mRNA ex-
pression determined by NGS, and p < 0.05 for comparisons
of levels of mRNA expression determined by qRT-PCR.
Each time series of clock gene expression levels was ana-
lyzed for circadian rhythm characteristics by the single
cosinor procedure involving the fit of a 24-h cosine curve
to the data by least squares linear regression, in order to
accurately describe waveforms and rhythm characteristics.
An R2 value and a p value for the rejection of the zero-
amplitude assumption were determined for each compo-
nent in the cosine model separately and overall, with
rhythm detection considered statistically significant if
p ≤ 0.05 and borderline significant if p > 0.05 and p < 0.10
for any period tested. Circadian (24-h) characteristics were
summarized from the 24-h cosine. Rhythm characteristics
determined from the best-fitting cosine model include the
MESOR (the middle of the cosine representing an adjusted
average if unequal sampling), the amplitude (half the dis-
tance from the peak and trough of the best fitting curve),
and the acrophase of the cosine model (the peak of a single
component cosine). All analyses were performed using
the MATLAB 6.5 statistical package (MathWorks, Natick,
MA, USA).
Results
The mRNA expression levels of the core clock genes
ARNTL, ARNTL2, CLOCK, CRY1, CRY2, CSNK1D,
CSNK1E, CSNK2A1, CSNK2A2, CSNK2B, NPAS2, NR1D1,
NR1D2, PER1, PER2, PER3, RORA, SIRT1, TIMELESS,
TIPIN and of a set of clock controlled genes were evaluated
as part of a whole transcriptome analysis performed by
NGS technology in healthy human fibroblasts (C) and
fibroblasts of HS patients before (H), 24 hours (T1) and
144 hours (T2) after idursulfase treatment. Ratio, log2
(ratio), fold change and p-values are shown in Additional
file 1: Table S1.The expression levels of ARNTL, ARNTL2, CLOCK,
CRY1, PER1, PER2, and PER3 were also evaluated by
qRT-PCR after serum-shock induced synchronization in
normal human fibroblasts and fibroblasts of patients af-
fected by HS before and after 24 hours of treatment with
idursulfase.
Evaluation by NGS technology of core clock gene
expression in HS fibroblasts vs healthy fibroblasts (H vs C)
In HS fibroblasts the genes CLOCK (fold change = −1.45,
p < 0.0001), NPAS2 (fold change = −1.65, p < 0.0001),
CRY1 (fold change = −1.51, p < 0.0001), NR1D2 (fold
change = −1.97, p < 0.0001) and SIRT1 (fold change = −1.30,
p < 0.0001) showed lower expression levels compared to
healthy controls. Conversely the genes PER1 (fold change =
1.27, p < 0.0001), CSNK1D (fold change = 1.26, p < 0.0001),
CSNK1E (fold change = 1.54, p < 0.0001), and NR1D1
(fold change = 1.99, p < 0.0001) showed higher expression
levels in HS fibroblasts. The expression level of ARNTL
(fold change = 1.34, p = 0.01), ARNTL2 (fold change =
1.09, p = 0.47), PER2 (fold change = 1.40, p = 0.001), PER3
(fold change = −1.01, p = 0.79), CRY2 (fold change = 1.16,
p = 0.02), CSNK2A1 (fold change = 1.02, p = 0.56),
CSNK2A2 (fold change = −1.08, p = 0.26), RORA (fold
change = −1.07, p = 0.28), TIMELESS (fold change = 1.25,
p = 0.006), and TIPIN (fold change = −1.25; p = 0.27) was
not different in a statistically significant way between nor-
mal and HS fibroblasts or did not reach the p < 0.001
threshold value.
Evaluation by NGS technology of core clock gene
expression levels in HS fibroblasts after 24 hours of
treatment with idursulfase versus healthy fibroblasts
(T1 vs C)
In HS fibroblasts after 24 hours of treatment with
idursulfase NPAS2 (fold change = −1.39, p = 0.0005),
CRY1 (fold change = −1.75, p < 0.0001) and NR1D2 (fold
change = −1.65, p < 0.0001) genes showed lower expres-
sion levels in comparison to controls. The genes ARNTL
(fold change = 1.53, p < 0.0001), ARNTL2 (fold change =
2.22, p < 0.0001), PER2 (fold change = 1.72, p < 0.0001),
CSNK1E (fold change = 1.47, p < 0.0001), CSNK2B (fold
change = 1.15, p < 0.0001), NR1D1 (fold change = 3.59,
p < 0.0001), and TIMELESS (fold change = 2.41, p < 0.0001)
showed higher expression levels in HS fibroblasts after 24 h
treatment, in comparison to healthy human fibroblasts.
The expression level of CLOCK (fold change = −1.13,
p = 0.003), PER1 (fold change = 1.22, p = 0.004), PER3
(fold change = 1.14, p = 0.03), CRY2 (fold change = 1.04,
p = 0.55), CSNK2A1 (fold change = 1.04, p = 0.30),
CSNK1D (fold change = 1.12, p = 0.007), CSNK2A2 (fold
change = −1.09, p = 0.25), RORA (fold change = −1.14,
p = 0.03), SIRT1 (fold change = −1.12, p = 0.07) and TIPIN
(fold change = 1.4; p = 0.03) was not different in a
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idursulfase treated HS fibroblasts or did not reach the p <
0.001 threshold value.
Evaluation by NGS technology of core clock gene
expression levels in HS fibroblasts 144 hours after
treatment with idursulfase versus healthy fibroblasts
(T2 vs C)
In HS fibroblasts 144 hours after treatment with
idursulfase the genes CLOCK (fold change = −1.66,
p < 0.0001), NPAS2 (fold change = −1.56, p < 0.0001),
CRY1 (fold change = −2.00, p < 0.0001), NR1D2 (fold
change = −2.53, p < 0.0001), RORA (fold change = −1.28,
p = 0.0003), TIMELESS (fold change = −1.93,
p < 0.0001) and SIRT1 (fold change = −1.41, p < 0.0001)
showed lower expression levels in comparison to controls.
CSNK1E (fold change = 1.27, p < 0.0001), and NR1D1
(fold change = 1.72, p < 0.0001) showed higher expression
levels in HS fibroblasts 144 hours after idursulfase treat-
ment in comparison to healthy human fibroblasts. The
expression level of ARNTL (fold change = 1.38, p = 0.007),
ARNTL2 (fold change = −1.36, p = 0.03), PER1 (fold
change = 1.02, p = 0.70), PER2 ((fold change = 1.20
p = 0.10), PER3 (fold change = −1.08, p = 0.25),
CRY2 (fold change = 1.05, p = 0.48), CSNK1D (fold
change = 1.11, p = 0.01), CSNK2A1 (fold change = −1.14,
p = 0.02), CSNK2A2 (fold change = −1.29, p = 0.002),
CSNK2B (fold change = 1.00, p = 0.85), and TIPIN (fold
change = −1.64; p = 0.03) was not different in a statisti-
cally significant way between normal and idursulfase
treated HS fibroblasts or did not reach the p < 0.001
threshold value.
Evaluation by NGS technology of changes of clock gene
expression levels in HS fibroblasts after 24 hours of
treatment with idursulfase versus untreated HS
fibroblasts (T1 vs H)
In HS fibroblasts after 24 hours of treatment with IDS
CSNK2B (fold change = −1.60, p < 0.0001) showed lower
expression levels compared to untreated HS fibroblasts
(H). Conversely the genes CLOCK (fold change = 1.28,
p < 0.0001), ARNTL2 (fold change = 2.03, p < 0.0001),
NR1D1 (fold change = 1.80, p < 0.0001), NR1D2 (fold
change = 1.19, p < 0.001), and TIMELESS (fold change =
1.91, p < 0.0001) showed higher expression levels in HS
fibroblasts treated for 24 hours with idursulfase , in
comparison to untreated HS fibroblasts. The expression
level of NPAS2 (fold change = 1.18, p = 0.11), ARNTL1
(fold change = 1.14, p = 0.21), PER1 (fold change = −1.04,
p = 0.50), PER2 (fold change = 1.23, p = 0.02), PER3 (fold
change = 1.16, p = 0.02), CRY1 (fold change = −1.16, p =
0.09), CRY2 (fold change = −1.11, p = 0.11), CSNK1D (fold
change = −1.12, p = 0.05), CSNK1E (fold change = −1.05,
p = 0.20), CSNK2A1 (fold change = 1.01, p = 0.66),CSNK2A2 (fold change = −1.00, p = 0.98), RORA (fold
change = −1.07, p = 0.30), SIRT1 (fold change = 1.16,
p = 0.04), and TIPIN (fold change = 1.83; p = 0.01)
was not different in a statistically significant way between
treated and not treated HS fibroblasts or did not reach the
p < 0.001 threshold value.
Evaluation by NGS technology of changes of clock gene
expression levels in HS fibroblasts after 144 hours of
treatment with idursulfase versus untreated HS
fibroblasts (T2 vs H)
In HS fibroblasts after 144 hours of treatment with IDS
the genes CSNK1E (fold change = −1.12, p < 0.0001),
CSNK2A1 (fold change = −1.17, p < 0.001), CSNK2B
(fold change = −1.21, p < 0.0001), NR1D2 (fold
change = −1.28, p < 0.0001), and TIMELESS (fold
change = −2.4, p < 0.0001) showed lower expression
levels, in comparison to untreated HS fibroblasts.
The expression level of CLOCK (fold change = −1.14,
p = 0.009), NPAS2 (fold change = 1.05, p = 0.64),
ARNTL (fold change = 1.03, p = 0.78), ARNTL2 (fold
change = −1.48, p = 0.004), PER1 (fold change = −1.24,
p = 0.002), PER2 (fold change = −1.16, p = 0.14), PER3
(fold change = −1.06, p = 0.37), CRY1 (fold change = −1.32,
p = 0.002), CRY2 (fold change = −1.10, p = 0.15),
CSNK1D (fold change = −1.13, p = 0.004), CSNK2A2
(fold change = −1.18, p = 0.04), NR1D1 (fold change = −1.16,
p = 0.01), RORA (fold change = −1.19, p = 0.01), SIRT1 (fold
change = −1.08, p = 0.33), and TIPIN (fold change = −1.31;
p = 0.26) was not different in a statistically significant way be-
tween treated and not treated HS fibroblasts or did not reach
the p < 0.001 threshold value.
Evaluation by NGS technology of clock controlled gene
expression in healthy fibroblasts, untreated HS fibroblasts
and HS fibroblasts 24 hours and 144 hours after
treatment with idursulfase
Regarding to the clock controlled genes, in HS fibro-
blasts there was a statistically significant difference and
dynamic change with idursulfase treatment at the time
points considered of the expression of a huge number of
output genes involved in the control of important cellu-
lar and tissue processes. The cellular processes driven by
clock controlled genes differentially expressed with a
statistical significance reaching the p < 0.001 threshold
are represented by DNA transcription (AHR, ARNT,
CTNNB1, FOS, FOXL2, FOXO1, HIF1A, HSF1, ID2,
JUN, KEAP1, KITLG, KLF10, NFIL3, PPARA, PPARD,
PPARG, RARA, RXRA, SMAD4, SP1, SREBF1, SRF,
STAT1, STAT5A), post-translational modification and
degradation (FBXL3, SUMO3, USP5), biosynthesis
(ACSL1, AEBP1, ALAS1, APBB1, APBB1IP, APBB2,
BMPR1A, CEBPB, CREBBP, FASN, GYS1, HMGCR,
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ALDH1A3, ALDH1B1, ATF2, ATM, ATR, ATRIP,
BHLHE40, BHLHE41, BNIP3, CES1, CES2, CYP7B1, E2F1,
EGFR, EGR1, EIF2B3, HSP90AA1, HSPA1A, HSPA5,
HSPD1, GABARAPL1, GLO1, GLUL, HK1, LDHA,
LMAN1, LMAN2, MAOA, NPC1, PARP1, PCK2, PRDX2,
PYGL, SGMS2, ULK1, XBP1), transport (AP2A1, AP2M1,
IGFBP3, IGFBP5, LDLR, SLC22A15, SLC25A1, SLC27A1,
SLC7A8, SLC9A3R2, SLC9A9), DNA damage response
(ATM, ATR, ATRIP), and cell cycle control (CCNA2,
CCNB1, CCND1, CDK2AP1, CDKN1A, GADD45A,
MDM2,WEE1). The tissue processes influenced by
deregulated clock controlled genes are mainly represented
by inflammation, hemocoagulation and fibrinolysis
(ADAM17, A2M, FN1, ICAM1, IL6, ITGA5, MASP1,
MGST1, NFKBIA, PDGFRA, PDGFRB, PTGS2, SERPINE1,
SPP1, THBD, TFPI2, TRAF2,VEGFA).Figure 1 x-y plots representing the time related profiles of expression
synchronization with serum shock in control fibroblasts and fibroblas
treatment with iduronate-2-sulfatase. Original units standardized to T0 (
ANOVA followed by all pairwise multiple comparison procedures with StudEvaluation by qRT-PCR after Serum-Shock Induced
Synchronization of changes of clock gene expression levels
in healthy fibroblasts, untreated HS fibroblasts and HS
fibroblasts after 24 hours of treatment with idursulfase
After serum shock synchronization and qRT-PCR ana-
lysis, statistically significant differences were evidenced
in the mRNA expression levels of ARNTL2 at 10 h
(p = 0.036), PER1 at 4 h (p = 0.019), PER2 at 10 h
(p = 0.041) and 16 h (p = 0.043), between idursulfase
treated HS fibroblasts and untreated HS fibroblasts
(Figure 1). Fitting of cosine curves with a 24-hour period
to raw data and plotting as polarograms clock gene
expression levels in control fibroblasts and fibroblasts of
patients affected by HS before and after 24 hours of
idursulfase treatment (Figures 2, 3 and 4) evidenced
statistically significant and borderline significant rhythms
of clock gene expression, and advance of phase os-of ARNTL, ARNTL2, CLOCK, CRY1 PER1, PER2, and PER3 after
ts of patients affected by Hunter Syndrome before and after
1 h after serum shock) and combined for analyses. * p < 0.05 for
ent-Newman-Keuls Method.
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acrophase and p values are reported in Table 1.
Semantic hypergraph-based analysis of circadian gene
expression
The aim of this analysis was to determine the func-
tional groups of genes that play any key-role in the
development of HS. The analysis workflow is here
preliminary sketched: (i) RNA-Sequencing: Detection
of core clock gene and clock controlled gene expres-
sion profiles; (ii) Descriptive analysis and feature se-
lection: Selection of the most varying genes by the
ensemble of principal component analysis and linear
discriminant analysis; (iii) Qualitative hypergraph
building: Inference of weighted and signed hypergraphs;
(iv) Quantitative undirected graph construction: Math-
ematical agglomeration of weights over the edges; (v)
Weighted topology indices calculation: Computation
of several weighted topology indices for each nodeFigure 2 x-y plots showing from top to bottom the fitted cosine curv
circles) and polarograms of ARNTL, ARNTL2, CLOCK, CRY1 PER1, PER2,
shock in control fibroblasts. Original units standardized to T0 (1 h after s
analysis show the acrophases for the clock gene expression values. Radial a
corresponding to the acme and vector length represents the amplitude ofand normalization of individual fold changes by the
most discriminant index; (vi) Determination of the
strongest connected components: Hierarchical cluster-
ing and matching with critical biological functions
[35,36].Descriptive analysis and features selection
We have preliminarily assessed the expression variation of
clock genes and clock-controlled genes, through five differ-
ent states: HS (H) vs. Control (C), Treatment at time 1 (T1)
vs. C, Treatment at time 2 (T2) vs. C, and T1 vs. H, T2 vs.
H. We discarded genes that did not exhibit any relevant ex-
pression change between these states. We combine a prin-
cipal component analysis to determine those genes that
maximally vary through the first three components, and a
linear discriminant analysis to project the genes and their
expressions onto the most varying components’ axes
(Figures 5 and 6).es (continous line) superimposed on raw data (squares and
and PER3 expression levels after synchronization with serum
erum shock) and combined for analyses. Polarograms of cosinor
xis represents the time point (in degrees) after serum shock
the oscillation.
Figure 3 x-y plots showing from top to bottom the fitted cosine curves (continous line) superimposed on raw data (squares and
circles) and polarograms of ARNTL, ARNTL2, CLOCK, CRY1 PER1, PER2, and PER3 expression levels after synchronization with serum
shock in the fibroblasts of a patient affected by Hunter Syndrome before and after 24-h treatment with iduronate-2-sulfatase. Original
units standardized to T0 (1 h after serum shock) and combined for analyses. Polarograms of cosinor analysis show the acrophases for the clock
gene expression values. Radial axis represents the time point (in degrees) after serum shock corresponding to the acme and vector length
represents the amplitude of the oscillation.
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We have assembled a hypergraph connecting genes by
querying and merging a number of heterogeneous data
sources: (i) Interpro and PFAM (protein domains), (ii) Gene
Expression Omnibus (Co-localization and co-expression),
(iii) BIOGRID and IREF (genetic interactions), (iv)
PathwayCommons, IMID, NCI_NATURE, REACTOME,
KEGG and BIOCARTA (pathways), (v) BIOGRID, BIND,
HPRD, INTACT, MINT, MPPI and OPHID (physical inter-
actions) and (VI) curated literature (predicted interactions).
Two genes were connected by an edge, whenever at least
an interaction evidence of any of the above mentioned
interaction categories was found. Several pair of genes
resulted to be connected by more than one edge. We built
a weighted and signed hypergraph with weights over the
edges (carrying the reliability of the corresponding interac-
tions) and weights over the nodes (carrying the fold change
expression of the corresponding genes) [37-39].Quantitative undirected graph
We deterministically inferred an undirectedm graph
from our hypergraph, by applying an injective function
to the sets of weights over the edges connecting any two
pairs of genes. This simple agglomerative weighting
function takes the weights of the edges connecting any
two nodes in input, and gives a unique value in output.
Constitutively, it gives more and more importance to the
pairs that are connected by multiple edges.
WAB ¼ e
n
n
Xn
i¼1
WABi
where n is the number of edges connecting any two
nodes A and B, and i refers to the ith edge.
Thus, we obtain a new graph that contains the same set
of nodes, and individual edges connecting any two nodes,
with the newly calculated weights over them (Figure 7).
Figure 4 x-y plots showing from top to bottom the fitted cosine curves (continous line) superimposed on raw data (squares and
circles) and polarograms of ARNTL, ARNTL2, CLOCK, CRY1 PER1, PER2, and PER3 expression levels after synchronization with serum
shock in the fibroblasts of a patient affected by Hunter Syndrome before and after 24-h treatment with iduronate-2-sulfatase. Original
units standardized to T0 (1 h after serum shock) and combined for analyses. Polarograms of cosinor analysis show the acrophases for the clock
gene expression values. Radial axis represents the time point (in degrees) after serum shock corresponding to the acme and vector length
represents the amplitude of the oscillation.
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We calculated the closeness topology index for each
gene. We recall that the un-weighted formulation of
closeness between any two nodes of a graph measures
the length of their shortest paths. The concept of close-
ness originates from the inverse definition of farness,
namely as the inverse of the sum of the distance from a
node to all other nodes. Thus, the more important a
node is, the lower is its total distance to all other nodes.
Closeness can be regarded as a measure of how fast it
will take to spread information from a node to all other
nodes sequentially. Contrarily, the weighted formulation
of closeness takes into account paths whose lengths are
not the sum of the minimum number of hops from a
node to all other nodes, but the sum of the inverse
weights over the edges of the shortest paths from a node
to all other nodes. This formulation gives importance to
the reliability of a connection, when determining theessentiality of each node, thereby discriminating between
reliable and not-reliable interaction paths.
We have subjected the top 26 closest genes to other
well-known topological indices (i.e., degree, betweenness,
clustering coefficient and topological importance) and
found that 5 (i.e., AHR, HIF1A, CRY1, ITGA5 and
EIF2B3, see the plot below) were highly ranked by 4 out
of 5 indices (Table 2 and Figure 8).
Strongly connected components determination
After having scaled the individual fold changes with the
closeness values of each gene, we have finally determined
the collaborative actions of such genes by extracting the
most cohesive clusters out of their interaction network. We
performed a hierarchical clustering on the expression pro-
files of clock and clock controlled genes, by considering the
Squared Euclidean distance as metric. We have subjected
the found clusters to functional enrichment analysis against
Table 1 Parameters calculated by Cosinor analysis (fitting a cosine curve with a 24-hour period to raw data) of clock
gene expression levels after serum-shock induced synchronization in normal fibroblasts and fibroblasts of patients
affected by Hunter syndrome before and after 24 hours of treatment with idursulfase
Fibroblast of control subject 1 Fibroblast of control subject 2
MESOR Amplitude Acrophase P MESOR Amplitude Acrophase P
ARNTL 0.578 0.401 60° 42′ 0.048 ARNTL 0.872 0.095 130° 30′ 0.747
ARNTL2 0.753 0.186 131° 58′ 0.734 ARNTL2 0.802 0.041 72° 33′ 0.948
CLOCK 0.834 0.061 45° 00′ 0.749 CLOCK 0.642 0.096 11° 11′ 0.827
PER1 0.813 0.106 51° 40′ 0.592 PER1 0.621 0.108 336° 40′ 0.818
PER2 0.777 0.271 277° 45′ 0.234 PER2 0.772 0.030 164° 21′ 0.983
PER3 0.420 0.469 258° 57′ 0.136 PER3 0.645 0.185 241° 35′ 0.825
CRY1 0.747 0.184 324° 45′ 0.577 CRY1 0.704 0.091 319° 46′ 0.842
Fibroblast of Hunter syndrome patient 1 not treated Fibroblast of Hunter syndrome patient 1 treated with idursulfase
MESOR Amplitude Acrophase P MESOR Amplitude Acrophase P
ARNTL 0.709 0.190 139° 04′ 0.493 ARNTL 0.499 0.406 69° 11′ 0.444
ARNTL2 0.466 0.383 204° 48′ 0.280 ARNTL2 0.597 0.110 101° 49′ 0.928
CLOCK 0.600 0.218 232° 42′ 0.825 CLOCK 0.500 0.255 37° 52′ 0.492
PER1 0.813 0.207 261° 52′ 0.516 PER1 0.321 0.257 28° 38′ 0.677
PER2 0.600 0.282 315° 00′ 0.294 PER2 0.585 0.196 330° 15′ 0.509
PER3 0.553 0.193 268° 32′ 0.867 PER3 0.484 0.350 305° 17′ 0.390
CRY1 0.461 0.253 161° 40′ 0.643 CRY1 0.399 0.237 2° 15′ 0.593
Fibroblast of Hunter syndrome patient 2 not treated Fibroblast of Hunter syndrome patient 2 treated with idursulfase
MESOR Amplitude Acrophase P MESOR Amplitude Acrophase P
ARNTL 0.552 0.365 103° 12′ 0.298 ARNTL 0.462 0.407 83° 41′ 0.163
ARNTL2 0.680 0.310 114° 09′ 0.260 ARNTL2 0.660 0.219 96° 41′ 0.349
CLOCK 0.662 0.316 119° 17′ 0.078 CLOCK 0.723 0.235 64° 40′ 0.296
PER1 0.597 0.169 54° 28′ 0.713 PER1 0.576 0.323 70° 31′ 0.235
PER2 0.420 0.196 9° 22′ 0.708 PER2 0.535 0.229 307° 31′ 0.682
PER3 0.383 0.257 322° 27′ 0.664 PER3 0.449 0.308 305° 32′ 0.572
CRY1 0.585 0.502 116° 45′ 0.009 CRY1 0.694 0.302 13° 30′ 0.039
Cosinor, least-squares fit of single component cosine to all data. MESOR, rhythm-adjusted overall 24 h mean; Amplitude, peak-trough range of cosine model ;
Acrophase, peak of cosine in degrees.
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http://www.biomedcentral.com/1755-8794/6/37the GO FAT category, and determined five clusters signifi-
cantly associated to at least a biological process or pathway
(Figure 9).
Cluster 1, which is made of CDK1, PER2, CCNA2,
JUN, PER1, TIMELESS, CCNB1, CSNK2B, EIF2B3,
NR1D1, ARNTL2, HSP90AA1, CSNK1D, E2F1,
BHLHE40, CEBPB, TIPIN, ELAVL1, ATRIP, POLA1,
MDM2, POLD1, HSPD1, HK1, LDHA, TRAF2, HSPA5,
TBP, PPP5C, ALDH1A3, CCRN4L, CDC7, SUMO3,
AHCY, POR, GNB2L1, ESRRA, ATP6V1D, USP5,
DDX11, NRF1, FOXL2, is strongly associated with sev-
eral cellular processes: cell cycle (GO:0022402, p-value =
1.46E-02; GO:0000278, p-value = 2.40E-03; etc.), DNA
damage response activities (GO:0000077, p-value =
1.055E-3; GO:0007050, p-value = 4.634E-3, etc.) and
pathways, such as cell cycle (WikiPathways, WP179,
p-value = 2.443E-4), and hypoxia-inducible factor inthe cardiovascular system (BIOCARTA, p-value =
2.041E-2).
Cluster 2, which is made of ARNTL, RXRA, CREBBP,
ITGA5, SERPINE1, CCND1, CSNK1E, BHLHE41,
CDKN1A, FN1, PKM2, PTGS2, DBP, PPARD, HSF1,
THBD, IGFBP3, HSPA1A, AP2M1, TUBB, FASN,
P4HA2, ALAS1, ALDH1B1, CDK2AP1, GYS1, NOTCH1,
ADA, SLC7A8, SCG5, is associated to the inflammatory
response (GO:0006954, p-value = 3.043E-2), response
to lipid (GO:0033993, p-value = 1.346E-3), liver devel-
opment (GO:0001889, 1.025E-3) and cell motility
(GO:0048870, p-value = 3.889E-3; GO:0016477, p-value =
1.823E-3).
Cluster 3, which is made of WEE1, FOS, EGR1,
PDGFRB, FOXO1, PPARG, IL6, NFYB, A2M, PDGFRA,
PTGDS, ICAM1, IGFBP5, NFIL3, AEBP1, LGALS9, is in-
volved in the response to cold (GO:0009409, p-value =
Figure 5 Heat map of the core clock gene expression fold changes between untreated patients and control cases (H/C), patients 24 or
144 hours after treatment and control cases (T1/C and T2/C), treated and untreated patients (T1/H and T2/H). Cyan segments and a
density plot quantify the magnitude of intra class and global FCs, respectively.
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http://www.biomedcentral.com/1755-8794/6/373.126E-5) and glucose homeostasis (GO:0042593,
p-value = 5.443E-3).
Cluster 4, which is made of CLOCK, ARNT, PER3,
EIF2B5, NPAS2, CSNK2A1, CSNK2A2, GSK3B, ATR,
HDAC3, SIRT1, EIF2B2, PLAT, PARP1, HSF2, MYC,NFYA, RORA, CHEK2, ATM, NONO, KLF10, RBX1,
TPMT, KITLG, TTC1, SEC61G, SEC61A1, GCLC,
SLC29A1, RCC1, SLC9A8, APBB2, SRP9, CHMP1B,
ENOX2, SLC9A9, ITFG2, WDR5, AACS, cooperate with
genes in cluster 1 to negatively regulate cell cycle
Figure 6 Heat map of the clock-controlled gene expression fold
changes between untreated patients and control cases (H/C),
patients 24 or 144 hours after treatment and control cases (T1/
C and T2/C), treated and untreated patients (T1/H and T2/H).
Cyan segments and a density plot quantify the magnitude of intra
class and global FCs, respectively.
Mazzoccoli et al. BMC Medical Genomics 2013, 6:37 Page 12 of 20
http://www.biomedcentral.com/1755-8794/6/37(GO:0007050, p-value = 3.094E-3), to the response to
decreased oxygen levels (GO:0036293, p-value =
3.128E-2) and to participate to the P53 signaling
pathway (Pathway Ontology, PW:0000718, p-value =
1.466E-2).
Cluster 5, which is made of AHR, HIF1A, CRY1, RB1,
STAT1, NFKBIA, STAT5A, PRKCA, FBXL3, NR1D2,
NFE2L2, HES1, ACSL1, CXCL12, NNMT, NAMPT,
EGFR, FMR1, NPC1, PYGL, NACA, LDLR, GLUL,
GLO1, MGST1, BMPR1A, plays an important role in the
positive regulation of epithelial cell proliferation
(GO:0050678, p-value = 8.024E-7), response to lipid
(GO:0033993, p-value = 3.898E-4; GO:0071396, p-value =
3.709E-3), tissue morphogenesis (GO:0048729, p-value =
7.487E-4) and takes part in the adipogenesis pathway
(WikiPathways, WP236, p-value = 8.700E-4).
Discussion
The molecular oscillator ticking in every cell regulates
the customary sequence of intracellular activities,
allowing the coordination of key pathways and the
compartmentalization in the temporal dimension of
poorly-compatible biochemical processes [40]. Altered
functioning of the clock gene machinery may determine
loss of time-of-day specific transcription of clock genes
and clock controlled genes, causing severe deregulation
of cellular homeostasis, cell dysfunction and biochemical
and structural derangements that may lead to cell death
and tissue dysfunction [41].
The aim of our study was to evaluate the functioning
of the clock gene machinery in HS, and to address this
issue we analyzed and compared mRNA expression
levels of the core clock genes CLOCK, NPAS2, ARNTL1,
ARNTL2, PER1, PER2, PER3, CRY1, CRY2, CSNK1D,
CSNK1E, CSNK2A1, CSNK2A2,CSNK2B, NR1D1,
NR1D2, RORA, SIRT1, TIMELESS, TIPIN, and a set of
clock controlled genes in normal human fibroblasts
and fibroblasts derived from subjects affected by
Mucopolysaccharidosis type II. We also evaluated
in vitro the effects of the treatment with idursulfase on
circadian gene expression at different time points.
Analyzing data obtained from NGS we observed al-
tered mRNA levels of some of the clock genes and clock
controlled genes and a variable response to idursulfase
treatment.
In HS fibroblasts CLOCK and NPAS2 showed lower
expression levels. CLOCK and its paralog NPAS2 encode
Figure 7 (See legend on next page.)
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Figure 7 Undirected and weighted interaction network between core clock genes and clock controlled genes in five different states:
Hunter disease (H) vs. Control (C) (H/C), Treatment at time 1 (T1) vs. C (T1/C), Treatment at time 2 (T2) vs. C (T2/C) and T1 vs. H (T1/H),
T2 vs. H (T2/H). Nodes colors range from red (negative FC) to green (positive FC). Diameter of nodes is proportional to the magnitude of the FC.
Thickness of edges varies with the reliability of the interaction. Overall, the network exhibits the following global topological properties: clustering
coefficient = 0.293, connected components = 1, diameter = 4, radius = 2, centralization = 0.259, shortest paths = 35910 (100%), characteristic
path length = 2.002, average number of neighbors = 25.484, density = 0.135 and heterogeneity = 0.498.
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helix/Per-Arnt-Simpleminded (bHLH-PAS) domain fam-
ily, and represent key elements in the positive limb of
the transcriptional-translational feed-back loop that
drives circadian rhythmicity of the oscillatory functions
underlying cell homeostasis. In particular, their encoded
proteins have histone acetyltransferase activity and are
involved in chromatin remodeling with specificity for
histones H3/H4 [42]. ARNTL, the heterodimerization
partner of CLOCK and NPAS2, enhances their enzym-
atic function, and the decreased expression of these cen-
tral components of the molecular clock could hinder the
correct clock gene expression in the fibroblasts of
Mucopolysaccharidosis type II patients.
A lower expression level was found in HS fibroblasts for
CRY1, whereas PER1 was up-regulated. The mammalian
Period and Cryptochrome genes are both E-box-regulated
genes, but in peripheral tissues CRY1 mRNA expres-
sion peak is delayed by several hours with respect to
that of PER1. CRY1 usually shows evening-time ex-
pression and serving as a strong repressor at morning-
time elements ensures a delay in feedback repression
in the molecular clock. This phase delay in CRY1 tran-
scription is required for customary mammalian clock
function [43]. The E-box (CACGTG) is crucial for day-
time transcriptional activity and the delay originates
from interactions between the proximal E-box and
ROR response elements (RORE) present in the CRY1
promoter [44].
A higher expression level was found in HS fibroblasts
for CSNK1D and CSNK1E, encoding the serine/threo-
nine protein kinase casein kinase (CK) I δ and ε respect-
ively, which are key regulators of metazoan circadian
rhythmicity. CKI binds to and phosphorylates the Period
proteins, wich in turn interact with a variety of circadian
regulators, suggesting the possibility that CKI may inter-
act with and phosphorylate additional clock components
as well [45]. Cryptochrome proteins are phosphorylated
by CKI only when both proteins are bound to mamma-
lian Period proteins [12]. ARNTL is also a substrate for
CKI in vitro, and CKI activity positively regulates
ARNTL-dependent transcription from circadian pro-
moters in reporter assays [12]. CKI phosphorylates mul-
tiple circadian substrates and may exert its effects on
circadian rhythm in part by a direct effect on ARNTL-
dependent transcription [12,45]. The up-regulation ofthese protein kinases found in HS fibroblasts could play
a crucial role in the derangement of the clock gene ma-
chinery and the downstream controlled pathways, but
on the other hand CKs could represent important
molecular targets for new therapeutic approaches.
In HS fibroblasts we found higher expression of
NR1D1, and lower expression of NR1D2. NR1D1 and
NR1D2, activated by CLOCK/NPAS2:ARNTL/ARNTL2
heterodimers, code respectively for the orfan nuclear re-
ceptors REV ERBα and REV ERBβ, which realize a supple-
mentary loop amplifying and stabilizing the oscillation of
the molecular clockwork. REV-ERBα and REV-ERBβ act
as negative transcriptional regulators by binding RORE
in gene promoters, preventing the binding of the posi-
tive transcriptional regulator RORα, and negatively
regulating the expression of ARNTL, CLOCK, and CRY1
[46,47]. In addition, REV-ERBα is directly involved in
lipid metabolism antagonizing the opposite role of
RORα and inhibiting the expression of genes coding for
apolipoprotein C-III, a constituent of very-low-density
lipoproteins [48].
A lower expression level was found in HS fibroblasts
for SIRT1, which regulates metabolic and stress re-
sponses acting in concert with the circadian rhythm ma-
chinery [49]. SIRT1 is involved in a number of cellular
processes, including gene silencing at telomere and mat-
ing loci, and modulates cell survival by inhibiting apop-
tosis or cellular senescence induced by external
challenges, including DNA damage and oxidative stress
[50]. SIRT1 impinges on Ku70, peroxisome proliferator
activated receptors, p53 and the forkhead box O
(FOXO) family of transcription factors, and is modulated
by active regulator of SIRT1 (AROS), hypermethylated
in cancer 1 (HIC-1), deleted in breast cancer 1 (DBC1)
and E2F transcription factor 1 (E2F1) [49-51]. Interest-
ingly, E2F1 was greatly over-expressed in HS fibroblasts,
but normalized after 144 hours of IDS treatment,
whereas FOXO1 was severely down regulated, and
responded faintly to IDS treatment. Besides, in HS fibro-
blasts there was severe down-regulation with no re-
sponse to IDS treatment of NAMPT, encoding the
enzyme controlling the synthesis of nicotinamide aden-
ine dinucleotide (NAD+), a cofactor of SIRT1, linking
nutrient sensing and circadian regulation [52].
After 24 hours of treatment with idursulfase in fibro-
blasts of patients with Mucopolysaccharidosis type II the
Table 2 The top 26 closest genes subjected to other well-known topological indices (i.e., degree, betweenness, clustering coefficient and topological
importance)
Gene Degree Gene Betweenness Gene Closeness Gene Clustcoefficient Gene Top Importance
CDK1 1.16518997973136 AEBP1 0.0391432466904165 AP2M1 24.1307228971342 CCNB1 0.667477524717011 HIF1A 2.82727459653061
ARNTL 0.62961382177992 GABARAPL1 0.0337159695650262 AEBP1 24.0044419343927 WEE1 0.327773492337581 TP53 2.2936294377538
WEE1 0.551381703183312 AP2M1 0.0322382020495228 ALAS1 23.9091457589775 EIF2B2 0.144963120091208 JUN 2.27910640635946
CLOCK 0.541276442699399 CDK2AP1 0.0315960768790957 MADD 23.610217143035 NFE2L2 0.127090889959061 AHR 2.08641066658505
ARNT 0.510341236219266 CRY1 0.0260192637551128 SCG5 23.5584599878639 PER3 0.091787769071256 MAPK3 1.99897079303812
PER2 0.470238863055953 HK1 0.020820688745217 CDK2AP1 23.5469067680977 DBP 0.0907867845842636 ARNTL 1.95211068089632
CCNA2 0.439051786404152 PCBD1 0.0200202313409861 PKM2 23.4572802663874 CRY1 0.082970740931625 BHLHE40 1.94713716381873
AHR 0.416056158700292 ALAS1 0.0183753353564674 CYP7B1 23.4449074706404 CRY2 0.0756826260846772 PPARG 1.87394548486246
PER3 0.394401965276283 PKM2 0.0179531160663236 GABARAPL1 23.3945147175824 PER2 0.071064631749534 CEBPB 1.84665878053937
JUN 0.390762193059339 ITGA5 0.0178387650085763 HK1 23.1739586467746 ADA 0.0690243684292723 FOS 1.84102240012328
CRY2 0.389512630608661 HIF1A 0.017777191362097 SLC27A1 22.8176492281657 NACA 0.0657467403759448 NFIL3 1.7612499926888
PER1 0.385914004666131 MADD 0.0159827593789858 EIF2B3 22.5884323963263 EIF2B3 0.0615477588018198 AHCY 1.75501225622585
HIF1A 0.373867980001836 PDGFRB 0.0157804459691252 CSNK1E 22.5498678271054 NPAS2 0.0601731548069088 ITGA5 1.73523600034203
FOS 0.366660049188066 EIF2B3 0.0151383207986982 CRY1 22.5300456552822 CCNA2 0.0547892603398778 GSK3B 1.73339775429975
CRY1 0.343702809331051 PRKCA 0.0145929542155957 SERPINE1 22.4848488761108 PER1 0.0515484999929679 MYC 1.72885994647542
TIMELESS 0.305749308005903 CYP7B1 0.0142762897479879 AHR 22.3586129186158 BNIP3 0.0495391099313379 EGFR 1.71329372276415
RXRA 0.262643997630735 CEBPB 0.0135198135198135 LGALS9 22.252427091889 HK1 0.0452462291589491 CDKN1A 1.70167462718295
CCNB1 0.249481205055106 SCG5 0.013159167876149 LDLR 22.1424073916989 ARNTL2 0.0431626137068269 PDGFRB 1.67570618006341
RARA 0.212303842977224 CSNK2A1 0.0129216695254431 SRF 22.1323817719809 FBXL3 0.0427148551020932 NNMT 1.67192063943735
EIF2B5 0.211018680676354 NR1D2 0.0124202841183973 SEC61G 22.1049070311325 CLOCK 0.0395097804135942 AP2M1 1.64526410912342
NPAS2 0.205625544420401 HEBP1 0.0120684347099441 CEBPB 21.999792977691 TIMELESS 0.0393934593277985 PARP1 1.63582453346807
CSNK2A1 0.195935112886188 AHR 0.0118221401240269 HSF1 21.9210101165568 BHLHE41 0.0370993928249183 CDK1 1.54911430562063
CREBBP 0.190951965351357 CSNK1E 0.0117341777719136 ITGA5 21.8931454731799 BHLHE40 0.0359260940771708 VEGFA 1.48068779917142
CSNK2B 0.186506665124637 TP53 0.0113911245986718 GLUL 21.8821482612889 ARNTL 0.0343347266280929 HDAC3 1.47924179392207
ITGA5 0.186467727050273 LDLR 0.0112151998944452 PDGFRB 21.6377733649355 CSNK2A2 0.0294553443471268 AEBP1 1.46811686042305
EIF2B3 0.171980851648026 IGFBP5 0.0108985354268373 HIF1A 21.6135335177089 CCRN4L 0.0249820497668383 CCNA2 1.45373180796276
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Figure 8 Genes with the highest topological scores. AHR, HIF1A, CRY1, EIF2B3, and ITGA5 are among the top 26 most ranked genes by 4 out
of 5 indices.
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http://www.biomedcentral.com/1755-8794/6/37expression evaluated by NGS of the genes CLOCK,
ARNTL2, NR1D1, NR1D2, and TIMELESS showed
higher expression levels compared to untreated HS fi-
broblasts. This effect faded completely after 144 hours,
and at this time point CSNK1E, CSNK2A1, CSNK2B,
NR1D2, and TIMELESS genes showed decreasing ex-
pression levels. Accordingly, the evaluation by qRT-PCR
of clock gene expression upon synchronization through
serum shock of normal fibroblasts and fibroblasts ofFigure 9 Hierarchical clustering of the weighted interaction networks
profiles, evaluated by an Euclidean distance metrics.patients affected by Hunter syndrome before and after
24 hours of idursulfase treatment evidenced a statisti-
cally significant effect on the expression levels of
ARNTL2, PER1 and PER2, but only at the earlier time
points examined, with advance of the phase of oscilla-
tion of gene expression.
Regarding to the clock controlled genes, in Hunter syn-
drome fibroblasts there was alteration and dynamic change
with idursulfase treatment at the time point considered of. Genes are clustered according to the proximity of their expression
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http://www.biomedcentral.com/1755-8794/6/37the expression of a huge number of output genes involved
in the control of important cellular and tissue processes.
An example is represented by SERPINE1, which showed
higher expression levels in HS fibroblasts when compared
to healthy fibroblasts, increased after 24 hours of
idursulfase treatment, and decreased after 144 hours.
SERPINE1 codes for the plasminogen activator inhibitor
(PAI)-1, the major component of inhibitors of fibrinolysis,
whose activity shows a clear circadian oscillation peaking in
the early morning. CLOCK:ARNTL and CLOCK:ARNTL2
heterodimers activate the SERPINE1 promoter, driving the
circadian variation in circulating PAI-1, and CLOCK:
ARNTL2 heterodimer, binding two E-box enhancers in
the promoter, shows double capability to activate PAI-1
expression [53].
The timing of processes that underlay cell function and
the customary sequence of activation of key pathways de-
pend on the correct ticking of the biological clock. Accord-
ingly, the altered expression of clock controlled genes
found in HS fibroblasts could hinder normal output of the
clock gene machinery (BHLHE40, BHLHE41, NFIL3), and
cellular activities, such as DNA transcription (CTNNB1,
FOS, FOXL2, FOXO1, HIF1A, HSF1, ID2, JUN, KEAP1,
KITLG, KLF10, PPARA, PPARD, PPARG, RARA, RXRA,
SMAD4, SP1, SREBF1, SRF, STAT1, STAT5A), post-
translational modification and degradation (FBXL3,
SUMO3, USP5), lipid and glucose metabolism and biosyn-
thetic pathways (ACSL1, AEBP1, ALAS1, APBB1, APBB1IP,
APBB2, BMPR1A, CREBBP, FASN, GYS1, HMGCR,
INSIG2, LPIN1, NAMPT), molecular processing (ADA,
ALDH1A1, ALDH1A3, ALDH1B1, ATF2, CES1, CES2,
CYP7B1, E2F1, EGFR, EGR1, EIF2B3, HSP90AA1,
HSPA1A, HSPA5, HSPD1, GLO1, GLUL, HK1, LDHA,
LMAN1, LMAN2, MAOA, NPC1, PARP1, PCK2, PRDX2,
PYGL, SGMS2), molecular transport (AP2A1, AP2M1,
IGFBP3, IGFBP5, LDLR, SLC22A15, SLC25A1, SLC27A1,
SLC7A8, SLC9A3R2, SLC9A9), DNA damage response
(ATM, ATR, ATRIP), endoplasmic reticulum stress and un-
folded protein response (XBP1), xenobiotic response (AHR,
ARNT), autophagy (BNIP3, CEBPB, GABARAPL1, ULK1),
cell cycle control (CCNA2, CCNB1, CCND1, CDK2AP1,
CDKN1A, GADD45A, MDM2, WEE1), and tissue pro-
cesses, such as inflammation, hemocoagulation and fibrin-
olysis (ADAM17, A2M, FN1, ICAM1, IL6, ITGA5, MASP1,
MGST1, NFKBIA, PDGFRA, PDGFRB, PTGS2, SERPINE1,
SPP1, TFPI2, THBD, TRAF2,VEGFA) [27-30,54].
The semantic hypergraph-based analysis of circadian
gene expression brought out five gene clusters significantly
associated to at least one biological process or pathway (cell
cycle, DNA damage response, inflammation, liver develop-
ment, cell motility, glucose homeostasis, response to cold
and to decreased oxygen levels, the P53 signaling pathway,
the positive regulation of epithelial cell proliferation, tissue
morphogenesis, response to lipid, and the adipogenesispathway). Besides, five genes, AHR, HIF1A, CRY1, ITGA5,
and EIF2B3, were highlighted as top ranked by all the five
considered topological indices and characterized by multi-
faceted centrality nature in the network analysis of the cir-
cadian transcriptome. The results suggest an interesting
connection between circadian and hypoxic pathways and
the toxicological signal mediator, the Aryl Hydrocarbon Re-
ceptor (AHR). Upon xenobiotic binding, AHR transcrip-
tionally activates xenobiotic metabolizing enzymes and
regulates molecules involved in the signaling of nuclear
factor-erythroid 2-related factor-2 (Nrf2), p53 (TRP53), ret-
inoblastoma (RB1), and NF-κB, influencing cellular re-
sponses to oxidative stress and inflammation. Through
activation of these signaling pathways, regulation of cell
cycle, and interactions with hypoxia-inducible factors
(HIFs), AHR takes part in endogenous developmental func-
tions during hematopoietic stem-cell maintenance and
differentiation [55]. Intriguingly, the deficit of CRY pro-
teins causes constitutive NF–κB and protein kinase A sig-
naling activation, leading to unrelenting increase of
proinflammatory cytokines, and ITGA5 encodes a receptor
for fibronectin and fibrinogen, playing a role in chemotaxis,
leukocyte migration, cell-cell adhesion, angiogenesis, and
blood coagulation [56,57].
On the other hand, a cross-talk exists between circadian
and AHR signaling pathways at genetic, epigenetic and
proteomic level, and this interaction might play a role in
the regulatory influences maneuvered by circadian rhythmi-
city on cell physiology [58]. Regarding to the interaction be-
tween hypoxic pathways and AHR complex, it has been
proven that in endothelial cells AHR has a physiological
function in the absence of exogenous ligands, and upon ac-
tivation mediates toxicity of halogenated aromatic hydro-
carbons. In addition, evidence suggests that hypoxia
induces HIF dependent gene expression, significantly redu-
cing AHR expression level and AHR-mediated expression
of cytochrome P-450 phase I xenobiotic metabolizing en-
zyme CYP1A1 [59]. A cross-talk exists between hypoxic
and circadian pathways operated by the PAS protein family
members PER and CLOCK and HIF-1α. Interestingly, the
components of AHR, circadian and hypoxic pathways are
characterized by a PAS domain that serves as an interface
for protein-protein interactions [60]. Moreover, cell prolif-
eration and differentiation both in vitro and in vivo are
highly influenced by oxygen concentration, and neuronal
stem cell proliferation and neuronal and oligodendroglial
differentiation are enhanced by a mild level of hypoxia [61].
Intriguingly, EIF2B3 encodes one of the subunits of initi-
ation factor EIF2B, which catalyzes the exchange of
eukaryotic initiation factor 2-bound guanosine-diphosphate
(GDP) for guanosine-5'-triphosphate (GTP), representing
an essential factor for protein synthesis, and mutations in
this gene have been associated with neurodegenerative and
white matter diseases [62-64].
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sented by the limited number of patients, suffering from a
disease that is clinically heterogeneous in terms of onset, se-
verity and progression, the dynamic variation of expression
levels observed for core clock genes and clock controlled
genes in the fibroblasts of patients affected by HS at differ-
ent time points of treatment with idursulfase may be an in-
direct evidence of the key role played by the molecular
clock in the regulation of the complex array of cellular
functions in this mucopolysaccharidosis. A paradigm is rep-
resented by the altered expression of the clock controlled
genes NPC1 and SGMS2, which are down-regulated in
HS fibroblasts and increase temporarily after idursulfase
treatment.
Conclusion
Biological processes show time related variations driven
by genetically encoded oscillators operated by transcrip-
tional/translational feedback loops hardwired by the
clock genes and their coded circadian proteins. Data
obtained in our study show that circadian gene expres-
sion is variably altered in the fibroblasts of subjects af-
fected by HS, the treatment with idursulfase determines
some modifications in the expression levels of clock
genes and clock controlled genes, but these changes are
temporary and fade in the course of treatment. Altered
functioning of the clock gene machinery in HS may de-
termine severe deregulation of cellular homeostasis, cell
dysfunction and biochemical and structural derange-
ments that may lead to cell death. These alterations are
related to the key role played by the molecular clockwork
in the control of downstream gene expression regulating a
complex array of cellular functions, such as molecule bio-
synthesis, post-translational modification, processing,
transport, conjugation, internalization and degradation,
and cell processes such as cell cycle, autophagy, apoptosis
and DNA damage response.The alteration of clock gene
expression levels and the response to the deficient enzyme
suggest a direct involvement of the molecular clock ma-
chinery in the physiopathology of cellular derangements
that characterize Mucopolysaccharidosis type II, opening
the way to possible new therapeutic strategies.
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